Bandaram Pharma Packtech (BOM:524602) Beneish M-Score: -0.82 (As of Jul. 03, 2026)


BOM:524602 Bandaram Pharma Packtech Ltd BOM:524602
50 GF Score
Price ₹23.30
GF Value ₹35.79
Valuation Possible Value Trap
! 5 Warning Signs
View Full Analysis

What is Bandaram Pharma Packtech Beneish M-Score?

Bandaram Pharma Packtech BOM:524602 -7.06% 50 Beneish M-Score is -0.82 as of Jul. 03, 2026. GuruFocus rates BOM:524602 with a GF Score™ of 50/100 and a GF Value™ of ₹35.79 (Possible Value Trap). The stock has 5 warning signs investors should review. Among 370 Packaging & Containers companies, Bandaram Pharma Packtech ranks worse than 91.35% on this metric.

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Warning Sign:

Beneish M-Score -0.82 higher than -1.78, which implies that the company might have manipulated its financial results.

The historical rank and industry rank for Bandaram Pharma Packtech's Beneish M-Score or its related term are showing as below:

BOM:524602' s Beneish M-Score Range Over the Past 10 Years
Min: -1.14   Med: -0.82   Max: 3.61
Current: -0.82

During the past 13 years, the highest Beneish M-Score of Bandaram Pharma Packtech was 3.61. The lowest was -1.14. And the median was -0.82.


Bandaram Pharma Packtech Beneish M-Score Historical Data

* Premium members only.

The historical data trend for Bandaram Pharma Packtech's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bandaram Pharma Packtech Beneish M-Score Chart

Bandaram Pharma Packtech Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 3.61 -1.14 -0.82

Bandaram Pharma Packtech Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.14 0.00 0.00 0.00 -0.82

BOM:524602 vs SW, PKG, IP: Beneish M-Score Comparison

For the Packaging & Containers subindustry, Bandaram Pharma Packtech's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bandaram Pharma Packtech Beneish M-Score vs Packaging & Containers Industry

For the Packaging & Containers industry and Consumer Cyclical sector, Bandaram Pharma Packtech's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Bandaram Pharma Packtech's Beneish M-Score falls into.


BOM:524602
50GF Score
Bandaram Pharma Packtech Ltd BOM:524602
Beneish M-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bandaram Pharma Packtech Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Bandaram Pharma Packtech for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 1.2274+0.528 * 1.3726+0.404 * 1.1883+0.892 * 1.7023+0.115 * 1.4312
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 0+4.679 * 0.070799-0.327 * 0.9888
=-0.82

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar26) TTM:Last Year (Mar25) TTM:
Total Receivables was ₹397.3 Mil.
Revenue was ₹629.2 Mil.
Gross Profit was ₹90.7 Mil.
Total Current Assets was ₹569.9 Mil.
Total Assets was ₹758.6 Mil.
Property, Plant and Equipment(Net PPE) was ₹94.1 Mil.
Depreciation, Depletion and Amortization(DDA) was ₹9.7 Mil.
Selling, General, & Admin. Expense(SGA) was ₹0.0 Mil.
Total Current Liabilities was ₹343.3 Mil.
Long-Term Debt & Capital Lease Obligation was ₹100.5 Mil.
Net Income was ₹4.5 Mil.
Gross Profit was ₹0.0 Mil.
Cash Flow from Operations was ₹-49.2 Mil.
Total Receivables was ₹190.2 Mil.
Revenue was ₹369.6 Mil.
Gross Profit was ₹73.1 Mil.
Total Current Assets was ₹308.8 Mil.
Total Assets was ₹389.2 Mil.
Property, Plant and Equipment(Net PPE) was ₹39.5 Mil.
Depreciation, Depletion and Amortization(DDA) was ₹6.1 Mil.
Selling, General, & Admin. Expense(SGA) was ₹1.1 Mil.
Total Current Liabilities was ₹140.3 Mil.
Long-Term Debt & Capital Lease Obligation was ₹89.9 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(397.345 / 629.232) / (190.172 / 369.638)
=0.631476 / 0.514482
=1.2274

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(73.135 / 369.638) / (90.702 / 629.232)
=0.197856 / 0.144147
=1.3726

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (569.929 + 94.052) / 758.625) / (1 - (308.809 + 39.506) / 389.175)
=0.124757 / 0.104991
=1.1883

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=629.232 / 369.638
=1.7023

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(6.127 / (6.127 + 39.506)) / (9.737 / (9.737 + 94.052))
=0.134267 / 0.093815
=1.4312

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(0 / 629.232) / (1.129 / 369.638)
=0 / 0.003054
=0

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((100.518 + 343.252) / 758.625) / ((89.912 + 140.319) / 389.175)
=0.584966 / 0.591587
=0.9888

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(4.481 - 0 - -49.229) / 758.625
=0.070799

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Bandaram Pharma Packtech has a M-score of -0.82 signals that the company is likely to be a manipulator.

Frequently Asked Questions Learn more about Beneish M-Score →
What does a Beneish M-Score of -0.82 mean?
Bandaram Pharma Packtech (BOM:524602) has a Beneish M-Score of -0.82 as of Jul. 03, 2026. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Bandaram Pharma Packtech and its competitors. According to the industry distribution chart, Bandaram Pharma Packtech ranks #338 out of 370 companies in the Packaging & Containers industry, placing it in the top 91.4%.
Is Bandaram Pharma Packtech's Beneish M-Score too high?
Bandaram Pharma Packtech's current Beneish M-Score is -0.82. Based on the distribution chart, Bandaram Pharma Packtech ranks #338 out of 370 companies in the Packaging & Containers industry, which is in the bottom quartile relative to peers. Overall, Bandaram Pharma Packtech has a GF Score™ of 50/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Bandaram Pharma Packtech's Beneish M-Score compare to SW and PKG?
According to the Packaging & Containers industry distribution chart, Bandaram Pharma Packtech ranks #338 out of 370 companies for Beneish M-Score. This places Bandaram Pharma Packtech in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beneish M-Score for a Packaging & Containers company?
A good Beneish M-Score depends on the Packaging & Containers industry context. However, Beneish M-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beneish M-Score mean?
A high Beneish M-Score can signal that a stock is expensive relative to its fundamentals. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Bandaram Pharma Packtech and its competitors. Bandaram Pharma Packtech's current Beneish M-Score is -0.82. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bandaram Pharma Packtech stock overvalued right now?
Based on GuruFocus' analysis, Bandaram Pharma Packtech (BOM:524602) is currently considered Possible Value Trap. The stock's GF Value™ is ₹35.79, compared to a current price of ₹23.30 — trading 34.9% below its estimated fair value. The current Beneish M-Score is -0.82. Bandaram Pharma Packtech's overall GF Score™ is 50/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beneish M-Score calculated?
Beneish M-Score is calculated from a company's financial statements. For Bandaram Pharma Packtech (BOM:524602), the current Beneish M-Score is -0.82 as of Jul. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Bandaram Pharma Packtech (BOM:524602) Overvalued in 2026?

Based on GuruFocus' analysis, Bandaram Pharma Packtech stock appears to be undervalued. The current stock price of ₹23.30 is trading 34.9% below its estimated GF Value™ of ₹35.79. GuruFocus considers Bandaram Pharma Packtech to be Possible Value Trap.

Key valuation signals for BOM:524602:

  • Beneish M-Score: -0.82
  • GF Value™: ₹35.79 vs. price of ₹23.30 (34.9% below fair value)
  • GF Score™: 50/100 with 5 warning signs

No single metric tells the full story. See the BOM:524602 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Bandaram Pharma Packtech Business Description

Address Old Airport Road, 601, 5th Floor, Oxford Towers, Opp to Leela Palace Hotel, Kodihalli, Bangalore, KA, IND, 560008
Bandaram Pharma Packtech Ltd is an India-based company engaged in the manufacturing of paper products and packing materials with more focus on catering to the needs of the pharma, food, and beverages industry apart from undertaking logistics business. The company is engaged in the Trading of Paper boards and Recycled Waste Paper. The company has only one business segment procurement and supply of recycled paper.
50GF Score

Get the complete analysis for BOM:524602

Beneish M-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹23.30
Price
₹35.79
GF Value